The best treatment for pneumonia: New clues, but no definitive answers

Archives of Internal Medicine

Volumn 159, Issue 21, 1999, Pages 2511-2512

  Dowell, S F ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; EDITORIAL; HUMAN; MORTALITY; PNEUMONIA; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CEPHALOSPORINS; CLINICAL TRIALS; DRUG THERAPY, COMBINATION; FLUOROQUINOLONES; HUMANS; LENGTH OF STAY; MACROLIDES; PNEUMONIA, BACTERIAL; RISK; SEVERITY OF ILLNESS INDEX;

EID: 0033596082     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.21.2511     Document Type: Editorial

References (6)